Immunotherapy Subcommittee

Purpose
The Immunotherapy subcommittee evaluates NRG concepts that utilize immunotherapy for feasibility, safety, and potential translational objectives. Furthermore, the Immunotherapy subcommittee in conjunction with disease sites may propose concepts involving immunotherapy. This committee meets quarterly.

Scientific Program

Immunotherapy Subcommittee Leadership

Chair

Susanna Ulahannan, MD

Vice Chair

Janice Lu, MD, PhD
Committee Members

  • Amma Agyemang
  • Mariam AlHilli
  • Adanma Anji Ayanambakkam Attanathi
  • Harry D. Bear
  • Leslie Bradford
  • Pavani Chalasani
  • Jenny Chang
  • Jennifer H. Choe
  • Eileen Connolly
  • Jennifer F. De Los Santos
  • Maria Diab
  • Bently Doonan
  • Claire F. Friedman
  • Marina Frimer
  • Eugenia Girda
  • Oleg Gligich
  • Shalina Gupta-Burt
  • Daniel Haldar
  • Brian S. Henick
  • Hyunseok Kang
  • Juraj Kavecansky
  • Namita Khanna
  • Sarah H. Kim
  • Olivia Lara
  • Jyoti Mayadev
  • Yvonne M. Mowery
  • Neil Newman
  • Adam C. Olson
  • Ravi Patel
  • Rebecca L Porter
  • Nawal Shaikh
  • Travis T. Sims
  • Anna Spreafico
  • Kristen D. Starbuck
  • Janos L. Tanyi
  • Jonathan Thompson
  • Rachael B. Turner
  • Joan R. Tymon-Rosario
  • Susanna Ulahannan
  • John L. Wagner
  • Meng Welliver
  • Trisha Wise-Draper
  • Joseph Zenga

 

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.